HOME >> MEDICINE >> NEWS
British scientists receive Lasker Prize for discovering new treatment for rheumatoid arthritis

Two of Britain's leading biomedical researchers have received the prestigious 2003 Albert Lasker Award for Clinical Medical Research for their discovery of anti-TNF (tumour necrosis factor) treatment as an effective treatment for rheumatoid arthritis and other related diseases.

The Lasker Awards for basic clinical and medical research have come to be known as 'America's Nobels' and 66 recipients of the Lasker award have gone on to receive Nobel prizes. They were first awarded in 1946.

It is only the third time that Rheumatology research has been honoured with a Lasker Award. The first was for the discovery of corticosteroid in 1949; the second for joint replacement surgery in 1974, and anti-TNF treatment is the third.

Emeritus Professor Sir Ravinder Maini and Professor Marc Feldmann, both based at the Kennedy Institute of Rheumatology, a division of Imperial College London's Faculty of Medicine, at Charing Cross Hospital, began working together 20 years ago to establish which molecules in rheumatoid arthritis were driving the inflammation and joint destruction, seeking new avenues of treatment. Their research was funded by long-term core support by the Arthritis Research Campaign (arc), and involved a team of scientists and clinicians.

Rheumatoid arthritis is a chronic inflammatory disease affecting the immune system. It affects about 400,000 people in the UK, causing much pain, and progressive joint damage leading to chronic disability and reduced life expectancy. Previous treatment options still left almost half of all patients with symptoms of continuing disease, deterioration of physical function and progressive joint damage.

In a series of experiments using tissue taken from joints, Feldmann and Maini investigated the role of cytokines, protein messenger molecules that drive inflammation, and found that a number of proinflammatory cytokines were indeed present in the inflamed joints. However they found that a single cyt
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.co.uk
44-207-594-6712
Imperial College London
13-Sep-2003


Page: 1 2 3 4

Related medicine news :

1. British hospitals need clinical ethicists
2. Concerns over the future of childrens health care in British general practice
3. British conservatives should beware of Australian health service reforms
4. Heart disease risk in British men is overestimated
5. US women endure twice the surgical biopsies as British for same cancer detection rate
6. British public supports mercy killing
7. U.S., British scientific societies honor penicillin as International Chemical Landmark
8. British Adolescents Need Government Support To Help Clean Up Their Act
9. OHSU scientists test medication to treat involuntary weight loss
10. Earlier use of prostate cancer vaccines urged by Hopkins scientists
11. Tobacco industry pays scientists to challenge secondhand smokes link to infant death risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... therapy, with the ability to deliver targeted radiation to cancer cells while sparing ... in traditional BNCT research platforms. Engineered from the ground up for high reliability ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... in a variety of areas. This year’s bill proposed several updates to Vermont’s ... the statute governing group captive investments. The many enhancements included in this year’s ...
(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official ... Sardis Volunteer Fire Department. , As a small, volunteer-only department in rural Mississippi, ... the community and now, is the only department with life-saving equipment of this caliber ...
(Date:4/17/2019)... ... April 17, 2019 , ... With Fentanyl overdose deaths continuing to claim lives ... death toll by looking for an alternative to naloxone. Researchers are presenting their ... week. , Naloxone (often known by the name brand Narcan) has been utilized increasingly ...
(Date:4/17/2019)... ... April 17, 2019 , ... Ramneek Kumar Talwar and ... in Gwangju, Korea, and has highly evaluated and confirmed iRINGER’s technology, a product ... in discussion of a potential partnership since then. , After sharing ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Global Lyme Alliance (GLA), the ... and awareness, and Ranger Ready Repellents, a new EPA-registered brand of body-worn ... prevention, including the proper use of repellents, to safeguard the public from tick ...
(Date:4/17/2019)... ... April 17, 2019 , ... As an employer do you feel overwhelmed by all of the ... to use? How can you best engage your employees? Do you have the budget for ... Join benefits administration experts Mike Ehrle, SVP of Strategic Partnerships, Hodges-Mace and Jay ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Allegheny Health Network (AHN) and Gateway Health have launched a new program that ... life. , AHN’s Enhanced Pain Management Program brings together a range of ...
Breaking Medicine Technology:
Cached News: